Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Capital Expenditures (2020 - 2025)

GoHealth's Capital Expenditures history spans 6 years, with the latest figure at -$5.9 million for Q3 2025.

  • For Q3 2025, Capital Expenditures rose 17.27% year-over-year to -$5.9 million; the TTM value through Sep 2025 reached $13.6 million, up 271.16%, while the annual FY2024 figure was $13.7 million, 686350.0% up from the prior year.
  • Capital Expenditures for Q3 2025 was -$5.9 million at GoHealth, down from $2.8 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $13.6 million in Q4 2024 and bottomed at -$8.1 million in Q4 2023.
  • The 5-year median for Capital Expenditures is $501000.0 (2021), against an average of $762473.7.
  • The largest annual shift saw Capital Expenditures tumbled 35252.17% in 2023 before it surged 3574.19% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at -$2.1 million in 2021, then surged by 101.09% to $23000.0 in 2022, then crashed by 35252.17% to -$8.1 million in 2023, then surged by 267.9% to $13.6 million in 2024, then crashed by 143.29% to -$5.9 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Capital Expenditures are -$5.9 million (Q3 2025), $2.8 million (Q2 2025), and $3.0 million (Q1 2025).